SCTX
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Scribe Therapeutics presented new data advancing the potential of ultra-long-acting genetic medicines for cardiovascular disease at the American Heart Association Scientific Sessions 2026.Nov 18, 2026
- Scribe Therapeutics presented updated data on its PCSK9-targeting epigenetic silencing and LPA-targeting gene editing programs at the American Heart Association Scientific Sessions 2026.Nov 5, 2026